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Abstract: A myriad of titanium (Ti) surface modifications has
been proposed to hasten the osseointegration. In this con-
text, the aim of this study was to perform histomorphomet-
ric, cellular, and molecular analyses of the bone tissue grown
in close contact with Ti implants treated by anodic spark dep-
osition (ASD-AK). Acid-etched (AE) Ti implants either
untreated or submitted to ASD-AK were placed into dog
mandibles and retrieved at 3 and 8 weeks. It was noticed that
both implants, AE and ASD-AK, were osseointegrated at 3
and 8 weeks. Histomorphometric analysis showed differences
between treatments only for bone-to-implant contact, being
higher on AE implants. Although not backed by histomorpho-
metric results, gene expression of key bone markers was
higher for bone grown in close contact with ASD-AK and for
cells harvested from these fragments and cultured until sub-
confluence. Cell proliferation at days 7 and 10 and alkaline
phosphatase activity at day 10 was higher on AE surfaces.
No statistical significant difference was noticed for extracellu-
lar matrix mineralization at 17 days. Our results have shown
that the Ti fixtures treated by ASD-AK allowed in vivo
osseointegration and induced higher expression of key
markers of osteoblast phenotype, suggesting that this surface
treatment could be considered to produce implants for clini-
cal applications. VC 2012 Wiley Periodicals, Inc. J Biomed Mater Res
Part A: 100A: 3092–3098, 2012.
Key Words: anodic spark deposition, bone, dental implants,
titanium, surface modification
How to cite this article: Sverzut AT, de Albuquerque GC, Crippa GE, Chiesa R, Della Valle C, de Oliveira PT, Beloti MM, Rosa AL.
2012. Bone tissue, cellular, and molecular responses to titanium implants treated by anodic spark deposition. J Biomed Mater Res
Part A 2012:100A:3092–3098.
INTRODUCTION
The phenomenon referred to as osseointegration has
been the focus of implant research in the last 40 years
and with the aim of achieving faster bone growth on tita-
nium (Ti) implants to quicken the whole treatment proce-
dure, a plethora of surface treatments has been pro-
posed.1–4
Among the innumerous possibilities of surface treat-
ments, for example, sandblasting, acid etching, coating with
bioactive substances, an attractive technique to produce a
thin and porous layer on Ti surfaces containing calcium
and phosphate is known as anodic spark deposition (ASD).5
To improve osseointegration of ASD-treated Ti surfaces,
combinations of this method with different chemical treat-
ments have been under investigation.6,7 Speciﬁcally, the
technique involving two consecutive ASD stages, the ﬁrst
one in a P solution and the second in a Ca2þ solution,
followed by an alkali etching treatment (ASD-AK) is able
to produce a unique nanostructured morphology and a
further modiﬁcation in the surface chemical composition.6
It has been demonstrated that this coating provides
more mechanical stability when compared to conventional
ASD.8
The performance of ASD-AK surfaces has been exten-
sively evaluated by using in vitro and in vivo models and
overall, promising outcomes have been reported.7–11 These
previous in vitro studies were carried out using immortal-
ized or primary osteoblasts cultured directly on ASD-AK
surfaces and in vivo evaluations were achieved by placing Ti
implants into animal (sheep, rabbit, and dog) long bones.
Thus, to date to our knowledge, the molecular and cellular
aspects of the cells grown in vivo on ASD-AK surfaces were
not investigated. In this context, we designed our study
based on dog mandibles as a more correlated model to the
clinical situation and carried out histomorphometric, cellu-
lar, and molecular analyses of the bone tissue grown in
close contact with ASD-AK Ti compared to the ‘‘gold stand-
ard’’ acid-etched (AE) Ti implants.
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MATERIALS AND METHODS
Treatment of Ti implants
We used 24 threaded Ti implants (3.75  8.5 mm) with AE
surface (Bioimplant, Trezzano sul Naviglio, Milano, Italy). A
surface modiﬁcation was made on 12 implants by ASD-AK
as described previously.6 Succinctly, the ﬁrst step was per-
formed in a solution containing P and Ca2þ, whereas the
second was performed in a solution containing only Ca2þ. A
variable DC power supply (BVR1200-500-1; Belotti Variatori
S.r.l., Milano, Italy) was used to provide electrical energy to
the circuit and the temperature of the electrolytic solution
was 0 6 2C. The Ti implants were connected to the anode
and a Ti cylindrical shaped net, 50 times bigger than the
anodizing sample surface, was used as cathode. A further al-
kali etching process was carried out in concentrated KOH
water solution. Twelve implants were left untreated (AE).
Surgical procedures
This study was carried out with six young adult mongrel
dogs weighting around 20 kg in conformity with the Com-
mittee of Ethics in Animal Research of the University of Sao
Paulo. The animals were anesthetized by intramuscular
injection of 2% Rompun 20–0.05 mL kg1 (Bayer, Porto Ale-
gre, Rio Grande do Sul, Brazil), and after sedation, an intra-
venous injection of thiopental (Cristalia, Itapira, Sao Paulo,
Brazil) 1 mL kg1 (20 mg kg1 thiopental diluted in 50 mL
saline) was administrated. After local anesthesia with 2%
mepivacaine plus adrenaline 1:100,000, full-thickness ﬂaps
were bilaterally elevated in the area from the ﬁrst to fourth
lower premolars. The teeth were extracted with no damage
to the bony walls, the sites were submitted to alveoloplasty,
gingivoplasty, curettage, and irrigation with saline solution,
and sutured with resorbable sutures. After 3 months, the
dogs were submitted to another surgical procedure to place
bilaterally two (two AE and two ASD-AK) Ti implants
according to a predeﬁned randomized protocol where one
implant of each treatment was placed in each hemimandi-
ble. For procedure, the dogs received intramuscularly injec-
tions of 20,000 UI of penicillin and erythromycin 0.1 g kg1
(Fort Dodge, Campinas, Sao Paulo, Brazil) starting on the
day before the surgery and then every 4 days during 2
weeks. Implants were allowed to heal without loading and
at 3 and 8 weeks postimplantation, the dogs were eutha-
nized with a lethal dose of pentobarbital (three animals per
period), and the bone segments containing the implants
were removed and processed for analysis. It is worth noting
that no samples were lost during the healing period. Sam-
ples from 3 and 8 weeks were processed for histological
and histomorphometric analyses. Furthermore, cellular and
molecular assays were carried out in samples from 3 weeks.
Histological and histomorphometric analyses
After harvesting, the samples were immersed in 10% forma-
lin buffered with 0.1M sodium cacodylate, pH 7.3, for 48 h
and they were kept in a solution of 70% ethanol for the
next 72 h. Bone segments were then dehydrated in graded
concentrations of ethanol and embedded in resin (LR White
Hard Grade, London, United Kingdom). After polymerization,
resin blocks were sectioned using Exakt Cutting System
(Exakt, Norderstedt, Germany) and the longitudinal mesio-
distal sections were polished and mounted on acrylic slides
using Exakt Grinding System (Exakt). The two resulting sec-
tions were further ground and polished to a thickness of 20
lm and stained with Stevenel’s blue and Alizarin red S.
Histological description of the adjacent tissues or in
direct contact with implants was done under light micros-
copy. Six implants per treatment per period were used for
histomorphometric analysis. The mean values of mesial and
distal measurements determined from the second thread
downward toward the ﬁfth one both mesially and distally
were used as described previously.12 The amount of bone at
the tissue–implant interface was expressed as the bone-to-
implant contact (BIC) and between threads as mineralized
bone area between threads (BABT). Furthermore, the miner-
alized bone area within mirror areas (BAMA) was deter-
mined as the symmetric area to the trapezoid between two
threads, sharing the larger base of the trapezoid to evaluate
parent bone content outside the threaded area (Fig. 1).13
Image analyses were carried out using pictures digitally
recorded from a Leica DMLB light microscope (Leica, Ben-
sheim, Germany), with N Plan (2.5/0.07, 10/0.25, 20/0.40)
and HCX PL Fluotar (40/0.75) objectives, outﬁtted with a
Leica DC 300F digital camera. A single trained and cali-
brated examiner (j ranging from 0.8 to 0.9) blinded to sur-
face treatments evaluated BIC using the Leica QWin soft-
ware (Leica Microsystems, Nussloch, Germany) and BABT
and BAMA using ImageJ software, version 1.34s (NIH, Be-
thesda, MD). Data from the three evaluated parameters (n ¼
6 for each one) were compared using two-way analysis of
variance followed by Tukey’s test when appropriated con-
sidering p  0.05. The statistical power, calculated using the
free software G*Power 3 (Heinrich-Heine University of Dus-
seldorf, Dusseldorf, Germany), was 83%.
Bone fragments harvesting
At 3 weeks, vestibular bone fragments 5 mm from the alve-
olar crest, 3 mm depth, and 2 mm wide were harvested
from all implants, the inner medullar portion was surgically
split up for assaying. Three of these fragments for each
implant treatment were randomly pooled and processed for
either cellular or molecular analyses as described below.
Cell culture
Osteoblastic cells from vestibular bone fragments in close
contact with either AE or ASD-AK implants were harvested
by enzymatic digestion as described elsewhere.11 The cells
were cultured in a-MEM (Gibco Life Technologies, Grand
Island, NY), supplemented with 5% fetal bovine serum
(Gibco), 50 lg mL1 gentamicin (Gibco), 0.3 lg mL1 fungi-
zone (Gibco), 107M dexamethasone (Sigma, St. Louis, MO),
5 lg mL1 ascorbic acid (Gibco), and 7 mM b-glycerophos-
phate (Sigma). Subconﬂuent cells in primary culture were
either used for real-time PCR assays or harvested and sub-
cultured in 24-well culture plates (Falcon, Franklin Lakes,
NJ) on Thermanox discs (Thermo Fisher Scientiﬁc–Nunc
GmbH & Co. KG, Rochester, NY) at a cell density of 2  104
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cells/well for culture growth, alkaline phosphatase (ALP) ac-
tivity and extracellular matrix mineralization experiments.
During the culture period, cells were incubated at 37C in a
humidiﬁed atmosphere of 5% CO2 and 95% air and the me-
dium was changed every 3 or 4 days.
Molecular analysis by real-time PCR
Gene expression was evaluated in samples from vestibular
bone fragments in close contact with both AE and ASD-AK
implants and cells harvested from these bone fragments
and cultured until subconﬂuence. Speciﬁc primers for the
osteoblast markers ALP, runt-related transcription factor 2
(RUNX2), osteocalcin (OC), type I collagen (COL), and bone
sialoprotein (BSP) were designed with Primer Express 2.0
(Applied Biosystems, Foster City, CA) and are summarized
in Table I.
The total RNA was extracted with Trizol reagent (Life
Technologies–Invitrogen, Carlsbad, CA) according to the
manufacturer’s instructions. The concentration and purity of
RNA samples were determined by optical density at a wave-
length of 260 and 260:280 nm, respectively and only sam-
ples presenting 260:280 ratios higher than 1.8 were ana-
lyzed. Complementary DNA (cDNA) was synthesized using 2
lg of RNA through a reverse transcription reaction (M–
MLVreverse transcriptase, Promega, Madison, WI). Real-time
PCR was carried out in a CFX96 Real-Time PCR Detection
System (Bio-Rad Laboratories, Philadelphia, PA) using Sybr-
Green PCR Master-Mix (Applied Biosystems, Warrington,
United Kingdom), speciﬁc primers and 2.5 ng of cDNA.
The standard PCR conditions were 50C (2 min), 95C (10
min), and 40 cycles of 95C (15 s), 60C (1 min), followed
by the standard denaturation curve. The relative gene
expression was calculated in reference to mitochondrial ri-
bosomal protein expression and normalized by the gene
expression of AE samples using the cycle threshold
method. The assays were conducted in triplicates (n ¼ 3)
and data were compared by Mann–Whitney test consider-
ing p  0.05.
Cellular analyses
Culture growth. The progression of culture growth was
evaluated at days 3, 7, and 10 by 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma). Cells
were incubated with 2 mL of MTT (5 mg mL1) in phos-
phate-buffered saline at 37C for 4 h. The solution was then
aspirated from the well and 1 mL of acid isopropanol
(0.04N HCl in isopropanol) was added. After shaking for 5
min, 1 mL of this solution was used to read the optical den-
sity at 570 nm on the plate reader (mQuant; Biotek,
Winooski, VT). The assays were carried out in quintupli-
cates (n ¼ 5), data were expressed as absorbance, which is
directly proportional to the number of proliferating and liv-
ing cells, and compared by Mann–Whitney test considering
p  0.05.
ALP activity. At day 10, the release of thymolphthalein
from thymolphthalein monophosphate was determined to
measure the ALP activity using a commercial kit (Labtest
Diagnostica SA, Belo Horizonte, Minas Gerias, Brazil) and
cell lysates obtained by ﬁve cycles of thermal shock (20C
for 20 min, and 37C for 15 min). Brieﬂy, 50 lL of thymol-
phthalein monophosphate was mixed with 0.5 mL of 0.3M
diethanolamine buffer, pH 10.1, and left for 2 min at 37C.
Then, 50 lL of the lysates from each well was added and af-
ter 10 min at 37C, 2 mL of a solution of Na2CO3 (0.09
mmol mL1) and NaOH (0.25 mmol mL1) was added to
allow color development. After 30 min, the absorbance was
measured at 590 nm using a spectrophotometer (Cecil
FIGURE 1. Overview of the evaluated histomorphometric parameters:
BIC (dashed line); mineralized BABT; and mineralized BAMA.
TABLE I. Primer Sequences, Annealing Temperature (Ta),
Melting Temperature (Tm), and Product Size (Bp) for
Real-Time PCR Reactions
Gene
Sense and Antisense
Sequences
Ta
(C)
Tm
(C) Bp
ALP TCAGGGAAACGAGGTCACCT 60 83 71
TGGTCACTATGCCCACAGATTT
RUNX2 CAAGGTTCAACGATCTGAGATTTG 60 80 85
GGAGGATTTGTGAAGACAGTTATGG
OC AGTATGCGAGCTCAACCCCAA 60 89 113
GTTTATTCTGGAGCAGCTGTGATG
BSP CAGAACTGCAAAAGGAAGCAATC 60 75.5 71
GGCCATTCCCAAAATGCTG
COL CTGCATGTCTAAGTGGTAGACATGC 59 80 145
CACGTGGTCCTCTATCTCCAGTT
MRPS GTGGGTGTGGTGGTTGGAA 60 82 90
CTCTCCCGACCTCTTTATCTGC
Abbreviations: ALP, alkaline phosphatase; RUNX2, runt-related tran-
scription factor 2; OC, osteocalcin; BSP, bone sialoprotein; COL, type I
collagen; MRPS, mitochondrial ribosomal protein (housekeeping
gene).
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CE3021, Cambridge, United Kingdom). The assays were
done in quintuplicates (n ¼ 5), the data were expressed as
ALP activity normalized by total protein content and com-
pared by Mann–Whitney test considering p  0.05.
Extracellular matrix mineralization. At day 17, cells were
ﬁxed in 10% formalin for 2 h at room temperature, dehy-
drated and stained with 2% Alizarin Red S (Sigma), pH 4.2,
for 10 min. The calcium content was evaluated using a col-
orimetric method. Brieﬂy, 280 lL of 10% acetic acid was
added to each well and the plate was incubated at room
temperature for 30 min under shaking. This solution was
vortexed for 1 min, the slurry was overlaid with 100 lL of
mineral oil (Sigma), heated to 85C for 10 min, and trans-
ferred to ice for 5 min. The slurry was centrifuged at
20,000g for 15 min and 150 lL of supernatant was mixed
with 60 lL of 10% ammonium hydroxide and this solution
was read at 405 nm in the plate reader lQuant (Biotek).
The assays were carried out in quintuplicates (n ¼ 5); data
were expressed as absorbance and compared by Mann–
Whitney test considering p  0.05.
RESULTS
Histological and histomorphometric analyses
From a histological point of view, we clearly noticed that
both Ti surfaces, AE and ASD-AK, were osseointegrated at 3
and 8 weeks, without ﬁbrous tissue in contact with implant
surfaces or signals of inﬂammation (Fig. 2). No remarkable
differences were observed from 3 to 8 weeks and between
surface treatments regarding tissue morphology. At 3 weeks,
both implant groups were partially surrounded by woven
and lamellar bone trabeculae, eventually lined by osteoid
and osteoblasts, indicating new bone formation. Only few
osteoclasts close to osteogenesis areas were noticed, sug-
gesting low resorbing activity. At the end of 8 weeks, the
amount of mineralized bone tissue was increased and areas
of active bone formation were still noticed on both AE and
ASD-AK implant surfaces. Furthermore, it was possible to
observe some areas of contact osteogenesis, at this time
point.
The results of histomorphometric evaluation are shown
in Table II and Figure 3. The percentage of BIC was affected
by the time of implantation (p ¼ 0.001) being higher at 8
weeks than at 3 weeks. Surface treatment also affected (p ¼
0.015) the percentage of BIC with higher values for AE com-
pared to ASD-AK implants irrespective of period of implan-
tation [Fig. 3(A)] as there is no statistical signiﬁcant differ-
ence for the interaction time vs. treatment (p ¼ 0.265).
The percentage of BABT was higher at 8 weeks (p ¼
0.001), but no statistical signiﬁcant difference either for
surface treatment (p ¼ 0.387) or for the interaction time
vs. treatment (p ¼ 0.584) was noticed [Fig. 3(B)]. The per-
centage of BAMA was higher at 8 weeks (p ¼ 0.050), but
FIGURE 2. Ground sections of AE and ASD-AK-treated Ti implants
surrounded by bone and connective tissues harvested at 3 and 8
weeks after implantation. At 3 and 8 weeks, lamellar bone trabeculae
and woven bone were observed adjacent to both AE and ASD-AK
implant surfaces. Such newly formed bone was frequently coupled
with parent lamellar bone. Alizarin red and Stevenel’s blue. Scale bar
¼ 200 lm. [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
TABLE II. Percentage of Bone Formation Around AE Ti Implants Either Untreated (AE) or Submitted to ASD-AK Treatment
Placed into Dog Mandibles and Harvested at 3 and 8 Weeksa
BIC (%) BABT (%) BAMA (%)
AE ASD-AK AE ASD-AK AE ASD-AK
3 Weeks 25.1 6 6.7 18.8 6 5.4 32.6 6 8.5 34.5 6 12.3 39.3 6 8.7 42.6 6 13.9
8 Weeks 46.9 6 10.9 31.0 6 8.6 65.3 6 15.6 73.7 6 7.0 54.8 6 17.4 56.1 6 13.9
a Data are presented as mean 6 confidence interval.
Abbreviations: BIC, bone-to-implant contact; BABT, mineralized bone area between threads; and BAMA, mineralized bone area within mirror
areas.
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again it was not affected by either surface treatment (p ¼
0.746) or the interaction time vs. treatment (p ¼ 0.889)
[Fig. 3(C)].
Molecular analysis by real-time PCR
After 3 weeks of implantation, the expression of genes
encoding RUNX2 (p ¼ 0.049) and COL (p ¼ 0.049) was
higher for samples of bone grown in close contact with
ASD-AK compared to AE implants. There was no statistical
difference for the expression of ALP (p ¼ 0.375), OC (p ¼
0.105), and BSP (p ¼ 0.827) genes [Fig. 4(A)].
After cell culture until subconﬂuence, gene expression
of ALP, OC, BSP, and COL (p ¼ 0.049 for all genes) was
higher for cultures derived from bone grown on ASD-AK
compared to AE implants. RUNX2 gene expression did not
exhibited statistical signiﬁcant difference (p ¼ 0.827) [Fig.
4(B)].
Cellular analysis
The cell proliferation was affected by the surface treatment
(p ¼ 0.001), being higher on AE compared to ASD-AK at
days 7 (p ¼ 0.009) and 10 (p ¼ 0.009), but not at 3 days
(p ¼ 0.645). The cell population progressively grown with
the time (p ¼ 0.001), exhibiting more cells on day 10 than
on day 7 and on day 7 than on day 3. The culture growth
was affected by the interaction time vs. treatment (p ¼
0.003) [Fig. 5(A)]. The ALP activity evaluated at day 10 was
higher (p ¼ 0.016) in cultures from bone samples grown
close to AE than to ASD-AK implants [Fig. 5(B)] and no
statistical signiﬁcant difference (p ¼ 0.407) was noticed
for extracellular matrix mineralization assayed at day 17
[Fig. 5(C)].
DISCUSSION
The use of dog mandible, bringing the experimental design
close to the clinical situation, and the evaluation of cellular
and molecular aspects of the newly bone formation in close
FIGURE 3. Percentage of bone formation around AE and ASD-AK
implants placed into dog mandibles and harvested at 3 and 8 weeks.
A: BIC; (B) mineralized BABT; and (C) mineralized BAMA. Data are
showed as mean 6 standard deviation (n ¼ 6).
FIGURE 4. Gene expression of osteoblast phenotype markers eval-
uated by real-time PCR. Gene expression of bone grown in close con-
tact with ASD-AK compared to AE implants (A) and of cells derived
from these bone samples and cultured until subconfluence (B). Aster-
isk indicates statistically significant difference (p  0.05) between
ASD-AK and AE surfaces. Data are shown as mean 6 standard devia-
tion (n ¼ 3).
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contact with implants make our ﬁndings relevant to clarify
the in vitro and in vivo bone responses to Ti treated by
ASD-AK technique. We have shown that gene expression of
critical markers of osteoblast phenotype was higher in both
bone fragments and cells harvested from these fragments
grown in close contact with ASD-AK compared to AE surfa-
ces. However, cellular parameters such as proliferation and
ALP activity were lower in cells from ASD-AK treatment,
whereas matrix mineralization was not signiﬁcantly affected.
In terms of histomorphometry, only BIC was lower on ASD-
AK than on AE implants. Thus, considering the distinct out-
come patterns raised from different experimental
approaches, we may suggest the association of in vitro and
in vivo assays to evaluate the biological responses to
implants.
Histomorphometric parameters are classically used to
investigate interactions between Ti implants and bone tis-
sue.14–17 Here, we evaluated BIC, BABT, and BAMA at 3 and
8 weeks for assessment of both early and late time points
of osseointegration, based on a previous study using the
same animal model, parameters, and time points.12 The
results indicate that all histomorphometric parameters
increased from 3 to 8 weeks, suggesting an active bone for-
mation during this period for both Ti implants. In addition,
ASD-AK surfaces were not able to support more bone for-
mation compared to AE ones. Indeed, BIC was higher on AE
surfaces irrespective of the evaluation period. Previously, we
did not observe signiﬁcant differences in terms of BIC by
comparing ASD-AK and machined Ti cylinders implanted
into dog humeri.10 Additionally, it has been reported that
surfaces treated by ASD elicit a positive effect on bone for-
mation compared to nontreated surfaces when Ti cylinders
or screw-thread ﬁxtures are implanted into long bones of
sheep and rabbit.7,18,19 The animal models and implant
designs used in these studies could explain contradictions
among the previous and present results. As in the present
study commercially available threaded Ti implants treated
by ASD-AK process were placed into dog mandibles using
clinically recommended protocols, we believe that the out-
comes are closely related to those expected from clinical
situations.
To extend our in vivo ﬁndings to a molecular level, gene
expression of osteoblast phenotype markers ALP, RUNX2,
OC, COL, and BSP was evaluated in bone samples harvested
from Ti implants at 3 weeks. Additionally, cells from these
bone fragments were cultured until subconﬂuence to assess
the same genes. As it is well known, bone formation is
directly regulated by the transcriptional factor RUNX2.20
The enzyme ALP hydrolyzes pyrophosphates to provide
inorganic phosphate to mineralize the extracellular matrix,
whose main component is COL.21,22 BSP and OC are noncol-
lagenous matrix proteins involved in nucleation of hydroxy-
apatite crystals and inhibition of mineralization, respec-
tively.23,24 RUNX2 and COL expression were higher in bone
fragments from ASD-AK implants, and in cells harvested
from these fragments, ALP, OC, COL, and BSP were upregu-
lated by ASD-AK compared to AE surfaces. Aligned with our
ﬁndings, it has been reported higher ALP and OC expression
in bone samples retrieved from anodically oxidized Ti com-
pared to machined implants.25 Despite no remarkable differ-
ences between both surfaces in terms of in vivo bone forma-
tion, ASD-AK treatment clearly induced alterations in the
intracellular machinery to promote the expression of osteo-
blast phenotype and this could represent an advantage to
favor implant osseointegration in compromised bone sites.
Cells from the same primary cultures derived from bone
fragments retrieved from ASD-AK and AE implants and used
to evaluate gene expression were subcultured for the
assessment of cellular parameters, that is, cell proliferation,
ALP activity, and extracellular matrix mineralization. We
noticed lower cell proliferation in cultures from ASD-AK
surface compared to AE one, which could be related to
more differentiated osteoblasts.26,27 In contrast, it has been
shown a tendency to higher proliferation rate in primary
and immortalized human cell cultures grown on ASD-AK
FIGURE 5. Cellular analysis of cells harvested from bone grown in
close contact with ASD-AK compared to AE implants. Cells were cul-
tured until subconfluence and subcultured for periods of up to 17
days. A: Cell proliferation evaluated at 3, 7, and 10 days; (B) ALP activ-
ity at day 10; and (C) extracellular matrix mineralization at day 17. As-
terisk indicates statistically significant difference (p  0.05) between
ASD-AK and AE surfaces at the same time point. Data are shown as
mean 6 standard deviation (n ¼ 5).
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surface.7,9,11 These divergent results could be owing to ei-
ther different cell sources or different experimental designs.
Although we used dog cells from bone grown in close con-
tact with Ti implants, other studies were carried out with
human cells directly cultured on Ti samples. ALP activity
was lower in cultures from ASD-AK implants than from AE
ones, whereas no signiﬁcant differences were noticed in the
amount of extracellular matrix mineralization. The minerali-
zation outcome matches both the present histomorphomet-
ric results and our earlier ﬁnding regarding the lack of
effect of ASD-AK treatment on in vitro bone-like nodule
formation.11
CONCLUSIONS
We have shown that ASD-AK-treated Ti induces higher
expression of key markers of osteoblast phenotype. Besides,
ASD-AK surface exhibited comparable cellular and histomor-
phometric responses to the ‘‘gold standard’’ AE surface with
only BIC being lower on ASD-AK than on AE implants. Con-
sidering differences in terms of sensitivity among in vivo,
cellular and molecular assays, we suggest that the associa-
tion of them is of relevance to evaluate Ti surface modiﬁca-
tions. As a ﬁnal point, further clinical outcomes are needed
to show that ASD-AK treatment could be considered for
implant therapy in impaired bone sites.
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